Big Move For Mersana Therapeutics, Inc.
Mon 14 Sep 20 at 05:36 PM
Mersana Therapeutics, Inc. (MRSN:NASDAQ) shot up at $24.17, representing a gain of 29.6%. On Fri 11 Sep 20, MRSN:NASDAQ hit a New 2-Week Intraday High of $19.23. The stock got featured on our News Catalysts scanner on Thu 10 Sep 20 at 08:40 AM in the 'BIOTECH' category. From Fri 28 Aug 20, the stock recorded 66.67% Up Days and 70.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Mersana Therapeutics, Inc. (MRSN:NASDAQ)
Mersana Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need.
Top 10 Gainers:
- Cassava Sciences, Inc. (SAVA:NASDAQ), 133.43%
- Immunomedics, Inc. (IMMU:NASDAQ), 97.99%
- Vaxart, Inc. (VXRT:NASDAQ), 46.79%
- NextDecade Corporation (NEXT:NASDAQ), 46.31%
- Scientific Games Corporation (SGMS:NASDAQ), 39.33%
- J.Jill, Inc. (JILL:NYSE), 37.51%
- Mersana Therapeutics, Inc. (MRSN:NASDAQ), 29.6%
- CBAK Energy Technology, Inc. (CBAT:NASDAQ), 26.16%
- Select Energy Services, Inc. (WTTR:NYSE), 25.56%
- Evogene Ltd. (EVGN:NASDAQ), 24.88%